Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: Genetic similarities

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 4 31-4, 2004, Pages

  Bauer, Alison K ^a   Malkinson, Alvin M ^b   Kleeberger, Steven R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Adenocarcinoma; Inflammation; Loci; Pneumotoxicant; Quantitative trait locus

Indexed keywords

1 [3 [5 (4 FLUOROPHENOXY) 2 FURYL] 1 METHYL 2 PROPYNYL] 1 HYDROXYUREA; ACETYLSALICYLIC ACID; ALLERGEN; BLEOMYCIN; BUDESONIDE; CORTICOSTERONE; DEXAMETHASONE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; OZONE; SULINDAC;

CANCER SUSCEPTIBILITY; CARCINOGENESIS; GENE EXPRESSION; GENETIC SIMILARITY; HISTOGENESIS; HISTOLOGY; HUMAN; HYPEROXIA; INFLAMMATION; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CANCER; LUNG DISEASE; LUNG INJURY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; LUNG; LUNG DISEASES; LUNG NEOPLASMS; MICE; OZONE;

EID: 4544265899     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00223.2003     Document Type: Review

References (255)

1. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, and Yang JX. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am. J Respir Crit Care Med 159: 373-382, 1999.
2. Adamson IY and Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77: 185-197, 1974.
3. Adriaenssens PI, Sivarajah K, Boorman GA, Eling TE, and Anderson MW. Effect of aspirin and indomethacin on the formation of benzo(a)pyrene-induced pulmonary adenomas and DNA adducts in A/HeJ mice. Cancer Res 43: 4762-4767, 1983.
4. Aldaz CM, Conti CJ, Gimenez IB, Slaga TJ, and Klein-Szanto AJ. Cutaneous changes during prolonged application of 12-O-tetradecanoyl-phorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res 45: 2753-2759, 1985.
5. Anderson GG and Cookson WO. Recent advances in the genetics of allergy and asthma. Mol Med Today 5: 264-273, 1999.
6. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, Burdick MD, Glass MC, Iannettoni MD, and Strieter RM. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 102: 465-472, 1998.
7. Bailey-Wilson JE, Wiest JS, Anderson MW, and Saccomanno G. Genetics of lung cancer. In: Biology of Lung Cancer, edited by Kane MA and Bunn PA. New York: Dekker, 1998, p. 53-98.
8. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13: 135-141, 2002.
9. Bauer AK, Dwyer-Nield LD, Keil K, Koski K, and Malkinson AM. Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp Lung Res 27: 197-216, 2001.
10. Bauer AK, Dwyer-Nield LD, and Malkinson AM. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis 21: 543-550, 2000.
11. Belinsky SA, Devereux TR, Foley JF, Maronpot RR, and Anderson MW. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res 52: 3164-3173, 1992.
12. Bergamaschi E, De Palma G, Mozzoni P, Vanni S, Vettori MV, Broeckaert F, Bernard A, and Mutti A. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am J Respir Crit Care Med 163: 1426-1431, 2001.
13. Bernert H, Sekikawa K, Radcliffe RA, Iraqi F, You M, and Malkinson AM. TNF-α and IL-10 deficiencies have contrasting effects on lung tumor susceptibility: gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog 38: 117-123, 2003.
14. Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, and Schmeichel KL. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res 59: 1757s-1763s; discussion 1763s-1764s, 1999.
15. Blomberg A, Mudway IS, Nordenhall C, Hedenstrom H, Kelly FJ, Frew AJ, Holgate ST, and Sandstrom T. Ozone-induced lung function decrements do not correlate with early airway inflammatory or antioxidant responses. Eur Respir J 13: 1418-1428, 1999.
16. Blyth DI, Pedrick MS, Savage TJ, Hessel EM, and Fattah D. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol 14: 425-438, 1996.
17. Bowden DH. Unraveling pulmonary fibrosis: the bleomycin model. Lab Invest 50: 487-488, 1984.
18. Bowden DH and Adamson IY. Bronchiolar and alveolar lesions in the pathogenesis of crocidolite-induced pulmonary fibrosis in mice. J Pathol 147: 257-267, 1985.
19. Bradley A. Mining the mouse genome. Nature 420: 512-514, 2002.
20. Brandes ME and Finkelstein JN. Stimulated rabbit alveolar macrophages secrete a growth factor for type II pneumocytes. Am J Respir Cell Mol Biol 1: 101-109, 1989.
21. Branstetter DG, Stoner GD, Budd C, Conran PB, and Goldblatt PJ. Effect of gestational development of lung tumor size and morphology in the mouse. Cancer Res 48: 379-386, 1988.
22. Brauer M, Blair J, and Vedal S. Effect of ambient ozone exposure on lung function in farm workers. Am J Respir Crit Care Med 154: 981-987, 1996.
23. Brockdorff N, Cross GS, Cavanna JS, Fisher EM, Lyon MF, Davies KE, and Brown SD. The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome. Nature 328: 166-168, 1987.
24. Camhi SL, Lee P, and Choi AM. The oxidative stress response. New Horiz 3: 170-182, 1995.
25. Canonico AE and Brigham KL. Biology of acute injury. In: The Lung (2nd ed.). edited by Crystal RG, West JB, Weibel ER, and Barnes PJ. Philadelphia, PA: Lippincott-Raven, 1997, p. 2475-2498.
26. Carstea ED, Morris JA, Coleman KA, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang T, Liscum L, Strauss JF, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O'Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady R, Vanier MT, Pentchev PJ, and Tagle DA. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277: 228-231, 1997.
27. Castonguay A, Rioux N, Duperron C, and Jalbert G. Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis. Exp Lung Res 24: 605-615, 1998.
28. Catane R, Schwade JG, Turrisi AT III, Webber BL, and Muggia FM. Pulmonary toxicity after radiation and bleomycin: a review. Int J Radiat Oncol Biol Phys 5: 1513-1518, 1979.
29. Chan K and Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96: 12731-12736, 1999.
30. Chen B, Johanson L, Wiest JS, Anderson MW, and You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA 91: 1589-1593, 1994.
31. Chen SJ, Vohr BR, and Oh W. Effects of birth order, gender, and intrauterine growth retardation on the outcome of very low birth weight in twins. J Pediatr 123: 132-136, 1993.
32. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, and Kleeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175-182, 2002.
33. Cho HY, Jedlicka AE, Reddy SP, Zhang LY, Kensler TW, and Kleeberger SR. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am J Respir Cell Mol Biol 26: 42-51, 2002.
34. Cho HY, Zhang LY, and Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-α receptors. Am J Physiol Lung Cell Mol Physiol 280: L537-L546, 2001.
35. Clements NC Jr, Nelson MA, Wymer JA, Savage C, Aguirre M, and Garewal H. Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am J Respir Crit Care Med 152: 1374-1378, 1995.
36. Cocco P, Rice CH, Chen JQ, McCawley M, McLaughlin JK, and Dosemeci M. Non-malignant respiratory diseases and lung cancer among Chinese workers exposed to silica. J Occup Environ Med 42: 639-644, 2000.
37. Cohen BH, Diamond EL, Graves CG, Kreiss P, Levy DA, Menkes HA, Permutt S, Quaskey S, and Tockman MS. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 2: 523-526, 1977.
38. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 402: B5-B11, 1999.
39. Corry DB and Kheradmand F. Induction and regulation of the IgE response. Nature 402: B18-B23, 1999.
40. Costa DL and Kodavanti UP. Toxic responses of the lung to inhaled pollutants: benefits and limitations of lung-disease models. Toxicol Lett 140-141: 195-203, 2003.
41. Coussens LM and Werb Z. Inflammation and cancer. Nature 420: 860-867, 2002.
42. Coussens LM and Werb Z. Inflammatory cells and cancer: think different! J Exp Med 193: F23-F26, 2001.
43. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le Souef PN, Lathrop GM, Musk AW, and Cookson WO. A genome-wide search for quantitative trait loci underlying asthma. Nature 383: 247-250, 1996.
44. Dano L, Guilly MN, Muleris M, Morlier JP, Altmeyer S, Vielh P, El-Naggar AK, Monehaux G, Dutrillaux B, and Chevillard S. CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer 29: 1-8, 2000.
45. Darvasi A and Soller M. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 141: 1199-1207, 1995.
46. Delfino RJ, Coate BD, Zeiger RS, Seltzer JM, Street DH, and Koutrakis P. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med 154: 633-641, 1996.
47. Delfino RJ, Murphy-Moulton AM, Burnett RT, Brook JR, and Becklake MR. Effects of air pollution on emergency room visits for respiratory illnesses in Montreal, Quebec. Am J Respir Crit Care Med 155: 568-576, 1997.
48. Devereux TR, Wiseman RW, Kaplan N, Garren S, Foley JF, White CM, Anna C, Watson MA, Patel A, Jarchow S, Maronpot R, and Anderson MW. Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mamm Genome 5: 749-755, 1994.
49. Dileto CL and Travis EL. Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis-prone and fibrosis-resistant mouse strain. Radiat Res 146: 61-67, 1996.
50. Donnelly PJ and Massey TE. Ki-ras activation in lung cells isolated from AC3F1 (A/J × C3H/HeJ) mice after treatment with aflatoxin B1. Mol Carcinog 26: 62-67, 1999.
51. Dragani TA, Hirohashi S, Juji T, Kawajiri K, Kihara M, Ono-Kihara M, Manenti G, Nomoto T, Sugimura H, Genka K, Yokota J, Takahashi T, Mitsudomi T, and Nagao M. Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res 60: 5017-5020, 2000.
52. Droms KA, Fernandez CA, Thaete LG, and Malkinson AM. Effects of adrenalectomy and corticosterone administration on mouse lung tumor susceptibility and histogenesis. J Natl Cancer Inst 80: 365-369, 1988.
53. Duffy DL, Martin NG, Battistutta D, Hopper JL, and Mathews JD. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 142: 1351-1358, 1990.
54. Duperron C and Castonguay A. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis 18: 1001-1006, 1997.
55. Dwyer-Nield LD, Paigen B, Porter SE, and Malkinson AM. Quantitative trait locus mapping of genes regulating pulmonary PKC activity and PKC-α content. Am J Physiol Lung Cell Mol Physiol 279: L326-L332, 2000.
56. Dwyer-Nield LD, Thompson JA, Peljak G, Squier MK, Barker TD, Parkinson A, Cohen JJ, Dinsdale D, and Malkinson AM. Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion. Toxicology 130: 115-127, 1998.
57. Ewart SL, Mitzner W, DiSilvestre DA, Meyers DA, and Levitt RC. Airway hyperresponsiveness to acetylcholine: segregation analysis and evidence for linkage to murine chromosome 6. Am J Respir Cell Mol Biol 14: 487-495, 1996.
58. Festing MF, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM, and You M. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice. Genomics 53: 129-136, 1998.
59. Festing MF, Yang A, and Malkinson AM. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet Res 64: 99-106, 1994.
60. Fijneman RJ, de Vries SS, Jansen RC, and Demant P. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 14: 465-467, 1996.
61. Fijneman RJ and Demant P. A gene for susceptibility to small intestinal cancer, ssicl, maps to the distal part of mouse chromosome 4. Cancer Res 55: 3179-3182, 1995.
62. Fijneman RJ, Jansen RC, van der Valk MA, and Demant P. High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14. Cancer Res 58: 4794-4798, 1998.
63. Fijneman RJ, Oomen LC, Snoek M, and Demant P. A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex. Immunogenetics 41: 106-109, 1995.
64. Finkelman FD, Katona IM, Urban JF Jr, Holmes J, Ohara J, Tung AS, Sample JV, and Paul WE. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 141: 2335-2341, 1988.
65. Food and Drug Administration. Butylated hydroxytoluene. Use restrictions. Federal Regulations 42: 27603-27609, 1997.
66. Forkert PG, Parkinson A, Thaete LG, and Malkinson AM. Resistance of murine lung tumors to xenobiotic-induced cytotoxicity. Cancer Res 52: 6797-6803, 1992.
67. Forsberg L, de Faire U, and Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389: 84-93, 2001.
68. Franko AJ, Sharplin J, Ward WF, and Taylor JM. Evidence for two patterns of inheritance of sensitivity to induction of lung fibrosis in mice by radiation, one of which involves two genes. Radiat Res 146: 68-74, 1996.
69. Gariboldi M, Manenti G, Canzian F, Falvella FS, Pierotti MA, Della Porta G, Binelli G, and Dragani TA. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res 53: 209-211, 1993.
70. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, Della Porta G, Binelli G, and Dragani TA. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet 3: 132-136, 1993.
71. Geara FB, Komaki R, Tucker SL, Travis EL, and Cox JD. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation. Int J Radiat Oncol Biol Phys 41: 279-286, 1998.
72. Gilmour MI, Hmieleski RR, Stafford EA, and Jakab GJ. Suppression and recovery of the alveolar macrophage phagocytic system during continuous exposure to 0.5 ppm ozone. Exp Lung Res 17: 547-558, 1991.
73. Ginsburg D and Bowie EJ. Molecular genetics of von Willebrand disease. Blood 79: 2507-2519, 1992.
74. Goldstein BD, Lai LY, Ross SR, and Cuzzi-Spada R. Susceptibility of inbred mouse strains to ozone. Arch Environ Health 27: 412-413, 1973.
75. Gonder JC, Proctor RA, and Will JA. Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci USA 82: 6315-6319, 1985.
76. Gressani KM, Leone-Kabler S, O'Sullivan MG, Case LD, Malkinson AM, and Miller MS. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene. Carcinogenesis 20: 2159-2165, 1999.
77. Grilli M, Pizzi M, Memo M, and Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274: 1383-1385, 1996.
78. Groot PC, Moen CJA, Hart AAM, Snoek M, and Demant P. Recombinant congenic strains-genetic composition. In: Genetic Variants and Strains of the Laboratory Mouse (3rd ed.), edited by Lyon MF, Rastan S, and Brown SDM. Oxford: Oxford University Press, 1996, p. 1660-1670.
79. Grupe A, Germer S, Usuka J, Aud D, Belknap JK, Klein RF, Ahluwalia MK, Higuchi R, and Peltz G. In silico mapping of complex disease-related traits in mice. Science 292: 1915-1918, 2001.
80. Guan X, Hardenbrook J, Fernstrom MJ, Chaudhuri R, Malkinson AM, and Ruch RJ. Down-regulation by butylated hydroxytoluene of the number and function of gap junctions in epithelial cell lines derived from mouse lung and rat liver. Carcinogenesis 16: 2575-2582, 1995.
81. Gunning WT, Castonguay A, Goldblatt PJ, and Stoner GD. Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol Pathol 19: 168-175, 1991.
82. Gunning WT, Kramer PM, Lubet RA, Steele VE, and Pereira MA. Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp Lung Res 26: 757-772, 2000.
83. Haddad EB, Salmon M, Koto H, Barnes PJ, Adcock I, and Chung KF. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-κB in rat lung: inhibition by corticosteroids. FEBS Lett 379: 265-268, 1996.
84. Halliwell B, Gutteridge JM, and Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 119: 598-620, 1992.
85. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 100: 57-70, 2000.
86. Harrison JH Jr and Lazo JS. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther 243: 1185-1194. 1987.
87. Harrison JH Jr and Lazo JS. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis. J Pharmacol Exp Ther 247: 1052-1058, 1988.
88. Haston CK and Travis EL. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 57: 5286-5291, 1997.
89. Haston CK, Wang M, Dejournett RE, Zhou X, Ni D, Gu X, King TM, Weil MM, Newman RA, Amos CI, and Travis EL. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet 11: 1855-1863, 2002.
90. Haston CK, Zhou X, Gumbiner-Russo L, Irani R, Dejournett R, Gu X, Weil M, Amos CI, and Travis EL. Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res 62: 3782-3788, 2002.
91. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, and Wiseman RW. Allelo-type analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 54: 6257-6264, 1994.
92. Heinzmann A and Daser A. Mouse models for the genetic dissection of atopy. Int Arch Allergy Immunol 127: 170-180, 2002.
93. Heston WE. Genetic analysis of susceptibility to induced pulmonary tumors in mice. J Natl Cancer Inst 3: 69-78, 1942.
94. Hizawa N, Freidhoff LR, Ehrlich E, Chiu YF, Duffy DL, Schou C, Dunston GM, Beaty TH, Marsh DG, Barnes KC, and Huang SK. Genetic influences of chromosomes 5q31-q33 and 11q13 on specific IgE responsiveness to common inhaled allergens among African American families. Collaborative Study on the Genetics of Asthma (CSGA). J Allergy Clin Immunol 102: 449-453, 1998.
95. Hoek G, Schwartz JD, Groot B, and Eilers P. Effects of ambient particulate matter and ozone on daily mortality in Rotterdam, The Netherlands. Arch Environ Health 52: 455-463, 1997.
96. Holt PG, Macaubas C, Stumbles PA, and Sly PD. The role of allergy in the development of asthma. Nature 402: B12-B17, 1999.
97. Hong SH, Ondrey FG, Avis IM, Chen Z, Loukinova E, Cavanaugh PF Jr, Van Waes C, and Mulshine JL. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J 14: 1499-1507, 2000.
98. Horowitz S, Dafni N, Shapiro DL, Holm BA, Notter RH, and Quible DJ. Hyperoxic exposure alters gene expression in the lung. Induction of the tissue inhibitor of metalloproteinases mRNA and other mRNAs. J Biol Chem 264: 7092-7095, 1989.
99. Hoyt DG and Lazo JS. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 246: 765-771, 1988.
100. Hubbard R, Venn A, Lewis S, and Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161: 5-8, 2000.
101. Huffman Reed JA, Rice WR, Zsengeller ZK, Wert SE, Dranoff G, and Whitsett JA. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol Lung Cell Mol Physiol 273: L715-L725, 1997
102. Iraqi F, Clapcott SJ, Kumari P, Haley CS, Kemp SJ, and Teale AJ. Fine mapping of trypanosomiasis resistance loci in murine advanced intercross lines. Mamm Genome 11: 645-648. 2000.
103. Islam SS and Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev 3: 289-298. 1994.
104. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322, 1997.
105. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, and Tuveson DA. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243-3248, 2001.
106. Jackson SH, Gallin JI, and Holland SM. The p47phox mouse knockout model of chronic granulomatous disease. J Exp Med 182: 751-758, 1995.
107. Jacob CO, Mykytyn K, Varcony T, and Drabkin HA. Mapping of the interleukin 5 receptor gene to human chromosome 3 p25-p26 and to mouse chromosome 6 close to the Raf-1 locus with polymorphic tandem repeat sequences. Mamm Genome 4: 435-439, 1993.
108. 2 synthases by ibuprofen, naproxen, and indomethacin. Biochem Pharmacol 62: 1587-1595, 2001.
109. Jeyapaul J and Jaiswal AK. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of γ- glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 59: 1433-1439, 2000.
110. Johnston CJ, Piedboeuf B, Rubin P, Williams JP, Baggs R, and Finkelstein JN. Early and persistent alterations in the expression of interleukin-1α, interleukin-1β and tumor necrosis factor-α mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res 145: 762-767, 1996.
111. Karhu R, Knuutila S, Kallioniemi OP, Siltonen S, Aine R, Vilpo L, and Vilpo J. Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group. Genes Chromosomes Cancer 19: 286-290, 1997.
112. Kauffman SL. Histogenesis of the papillary Clara cell adenoma. Am J Pathol 103: 174-180, 1981.
113. Kauffman SL, Alexander L, and Sass L. Histologic and ultrastructural features of the clara cell adenoma of the mouse lung. Lab Invest 40: 708-716, 1979.
114. Kauffmann F, Dizier MH, Annesi-Maesano I, Bousquet J, Charpin D, Demenais F, Ecochard D, Feingold J, Gormand F, Grimfeld A, Lathrop M, Matran R, Neukirch F, Paty E, Pin I, Pison C, Scheinmann P, Vervloet D, and Lockhart A. EGEA (Epidemiological study on the genetics and environment of asthma, bronchial hyperresponsiveness and atopy)-descriptive characteristics. Clin Exp Allergy 29, Suppl 4: 17-21, 1999.
115. Keith RL, Miller YE, Hoshikawa Y, Moore MD, Gesell TL, Gao B, Malkinson AM, Golpon HA, Nemenoff RA, and Geraci MW. Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res 62: 734-740, 2002.
116. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, and Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148: 3618-3623, 1992.
117. Kisley LR, Barrett BS, Bauer AK, Dwyer-Nield LD, Barthel B, Meyer AM, Thompson DC, and Malkinson AM. Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res 62: 6850-6856, 2002.
118. Kisley LR, Barrett BS, Dwyer-Nield LD, Bauer AK, Thompson DC, and Malkinson AM. Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis 23: 1653-1660, 2002.
119. Kleeberger SR, Bassett DJ, Jakab GJ, and Levitt RC. A genetic model for evaluation of susceptibility to ozone-induced inflammation. Am J Physiol Lung Cell Mol Physiol 258: L313-L320, 1990.
120. Kleeberger SR and Hudak BB. Acute ozone-induced change in airway permeability: role of infiltrating leukocytes. J Appl Physiol 72: 670-676. 1992.
121. Kleeberger SR, Levitt RC, Zhang LY, Longphre M, Harkema J, Jedlicka A, Eleff SM, DiSilvestre D, and Holroyd KJ. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat Genet 17: 475-478, 1997.
122. Kleeberger SR, Reddy S, Zhang LY, and Jedlicka AE. Genetic susceptibility to ozone-induced lung hyperpermeability: role of Toll-like receptor 4. Am J Respir Cell Mol Biol 22: 620-627, 2000.
123. Kleeberger SR, Reddy SP, Zhang LY, Cho HY, and Jedlicka AE. Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 280: L326-L333, 2001.
124. Kleeff J, Kusama T, Rossi DL, Ishiwata T, Maruyama H, Friess H, Buchler MW, Zlotnik A, and Korc M. Detection and localization of Mip-3α/LARC/ Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 81: 650-657, 1999.
125. Kopp EB and Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11: 13-18, 1999.
126. Korrick SA, Neas LM, Dockery DW, Gold DR, Allen GA, Hill LB, Kimball KD, Rosner BA, and Speizer FE. Effects of ozone and other pollutants on the pulmonary function of adult hikers. Environ Health Perspect 106: 93-99, 1998.
127. Kruglyak L and Lander ES. A nonparametric approach for mapping quantitative trait loci. Genetics 139: 1421-1428, 1995.
128. Lan Q, Chen W, Chen H, and He XZ. Risk factors for lung cancer in non-smokers in Xuanwei County of China. Biomed Environ Sci 6: 112-118, 1993.
129. Landis SH, Murray T, Bolden S, and Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
130. Lantry LE, Zhang Z, Yao R, Crist KA, Wang Y, Ohkanda J, Hamilton AD, Sebti SM, Lubet RA, and You M. Effect of farnesyl-transferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1- (3-pyridyl)-l-butanone. Carcinogenesis 21: 113-116, 2000.
131. Lemon WJ, Bernert H, Sun H, Wang Y, and You M. Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet 39: 644-655, 2002.
132. Lemon WJ, Palatini JJ, Krahe R, and Wright FA. Theoretical and experimental comparisons of gene expression indexes for oligonucleotide arrays. Bioinformatics 18: 1470-1476, 2002.
133. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, and Schellenberg GD. A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973, 1995.
134. Lin L, Festing MF, Devereux TR, Crist KA, Christiansen SC, Wang Y, Yang A, Svenson K, Paigen B, Malkinson AM, and You M. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res 24: 481-497, 1998.
135. Lubet RA, Zhang Z, Wiseman RW, and You M. Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res 26: 581-593, 2000.
136. Lynch CJ. Studies on the relation between tumor susceptibility and heredity. III. Spontaneous tumors of the lung in mice. J Exp Med 43: 339-355, 1926.
137. Maeda H and Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 63: 854-865, 1998.
138. Mahler M, Bristol IJ, Sundberg JP, Churchill GA, Birkenmeier EH, Elson CO, and Leiter EH. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics 55: 147-156, 1999.
139. Malkinson AM. The genetic basis of susceptibility to lung tumors in mice. Toxicology 54: 241-271, 1989.
140. Malkinson AM. Genetic studies on lung tumor susceptibility and histogenesis in mice. Environ Health Perspect 93: 149-159, 1991.
141. Malkinson AM. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res 24: 541-555, 1998.
142. Malkinson AM. Prevention of butylated hydroxytoluene-induced lung damage in mice by cedar terpene administration. Toxicol Appl Pharmacol 49: 551-560, 1979.
143. Malkinson AM. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res 52: 2670s-2676s, 1992.
144. Malkinson AM and Beer DS. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J Natl Cancer Inst 70: 931-936, 1983.
145. Malkinson AM, Koski KM, Dwyer-Nield LD, Rice PL, Rioux N, Castonguay A, Ahnen DJ, Thompson H, Pamukcu R, and Piazza GA. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis 19: 1353-1356, 1998.
146. Malkinson AM, Nesbitt MN, and Skamene E. Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model. J Natl Cancer Inst 75: 971-974, 1985.
147. Malkinson AM, Radcliffe RA, and Bauer AK. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis 23: 411-417, 2002.
148. Manenti G, Gariboldi M, Elango R, Fiorino A, De Gregorio L, Falvella FS, Hunter K, Housman D, Pierotti MA, and Dragani TA. Genetic mapping of a pulmonary adenoma resistance (Par1 ) in mouse. Nat Genet 12: 455-457, 1996.
149. Manenti G, Gariboldi M, Fiorino A, Zanesi N, Pierotti MA, and Dragani TA. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res 57: 4164-4166, 1997.
150. Manenti G, Gariboldi M, Fiorino A, Zedda AI, Pierotti MA, and Dragani TA. Pas1 is a common lung cancer susceptibility locus in three mouse strains. Mamm Genome 8: 801-804, 1997.
151. Manenti G, Stafford A, De Gregorio L, Gariboldi M, Falvella FS, Avner P, and Dragani TA. Linkage disequilibrium and physical mapping of Pas1 in mice. Genome Res 9: 639-646, 1999.
152. Mansour H, Levacher M, Azoulay-Dupuis E, Moreau J, Marquetty C, and Gougerot-Pocidalo MA. Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicity. J Appl Physiol 64: 1376-1381, 1988.
153. Maria DA, Manenti G, Galbiati F, Ribeiro OG, Cabrera WH, Barrera RG, Pettinicchio A, De Franco M, Starobinas N, Siqueira M, Dragani TA, and Ibanez OM. Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response. Oncogene 22: 426-432, 2003.
154. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, and Beaty TH. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264: 1152-1156, 1994.
155. Marshall KE, Godden EL, Yang F, Burgers S, Buck KJ, and Sikela JM. In silico discovery of gene-coding variants in murine quantitative trait loci using strain-specific genome sequence databases. Genome Biol 3: RESEARCH0078, 2002.
156. Martinez FD, Solomon S, Holberg CJ, Graves PE, Baldini M, and Erickson RP. Linkage of circulating eosinophils to markers on chromosome 5q. Am J Respir Crit Care Med 158: 1739-1744, 1998.
157. Mason RJ, Kalina M, Nielsen KD, Malkinson AM, and Shannon JM. SP-C expression in urethane induced murine pulmonary tumors. Am J Pathol 156: 175-182, 2000.
158. Mason RJ and Shannon JM. Alveolar type II cells. In: The Lung: Scientific Foundations, edited by Crystal RG, West JB, Barnes PJ, and Weibel ER. Philadelphia, PA: Lippincott-Raven. 1997, p. 543-555.
159. Mayne ST, Buenconsejo J, and Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149: 13-20, 1999.
160. McDonnell WF III, Horstman DH, Abdul-Salaam S, and House DE. Reproducibility of individual responses to ozone exposure. Am Rev Respir Dis 131: 36-40, 1985.
161. Miller AC, Dwyer LD, Auerbach CE, Miley FB, Dinsdale D, and Malkinson AM. Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain. Toxicology 90: 141-159, 1994.
162. Miyashita N and Moriwaki K. H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains. Jpn J Cancer Res 78: 494-498, 1987.
163. Moody TW, Leyton J, Zakowicz H, Hida T, Kang Y, Jakowlew S, You L, Ozbun L, Zia H, Youngberg J, and Malkinson A. Indomethacin reduces lung adenoma number in A/J mice. Anticancer Res 21: 1749-1755, 2001.
164. Morahan G, Huang D, Tait BD, Colman PG, and Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272: 1808-1810, 1996.
165. Moser AR, Dove WF, Roth KA, and Gordon JI. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116: 1517-1526, 1992.
166. Mudway IS and Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med 21: 1-48, 2000.
167. Nadeau JH. Maps of linkage and synteny homologies between mouse and man. Trends Genet 5: 82-86, 1989.
168. Nagase H, Bryson S, Fee F, and Balmain A. Multigenic control of skin tumour development in mice. Ciba Found Symp 197: 156-168; discussion 168-180. 1996.
169. Nasir J, Lin B, Bucan M, Koizumi T, Nadeau JH, and Hayden MR. The murine homologues of the Huntington disease gene (Hdh) and the α-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3. Genomics 22: 198-201, 1994.
170. Nemunaitis J, Klemow S, Tong A, Courtney A, Johnston W, Mack M, Taylor W, Solano M, Stone M, Mallams J, and Mues G. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung. Am J Clin Oncol 21: 155-160, 1998.
171. Obata M, Nishimori H, Ogawa K, and Lee GH. Identification of the Par2 (pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 13: 1599-1604, 1996.
172. Ober C. Susceptibility genes in asthma and allergy. Curr Allergy Asthma Rep 1: 174-179, 2001.
173. Ober C, Tsalenko A, Willadsen S, Newman D, Daniel R, Wu X, Andal J, Hoki D, Schneider D, True K, Schou C, Parry R, and Cox N. Genome-wide screen for atopy susceptibility alleles in the Hutterites. Clin Exp Allergy 29, Suppl 4: 11-15, 1999.
174. O'Byrne KJ and Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85: 473-483, 2001.
175. Ohtsuka Y, Brunson KJ, Jedlicka AE, Mitzner W, Clarke RW, Zhang LY, Eleff SM, and Kleeberger SR. Genetic linkage analysis of susceptibility to particle exposure in mice. Am J Respir Cell Mol Biol 22: 574-581, 2000.
176. Ohtsuka Y, Clarke RW, Mitzner W, Brunson K, Jakab GJ, and Kleeberger SR. Interstrain variation in murine susceptibility to inhaled acid-coated particles. Am J Physiol Lung Cell Mol Physiol 278: L469-L476, 2000.
177. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, and Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999.
178. Oomen LC, van der Valk MA, Hart AA, and Demant P. Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex. J Natl Cancer Inst 81: 512-517, 1989.
179. Osann KE. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 51: 4893-4897, 1991.
180. Otto-Knapp R, Jurgovsky K, Schierhorn K, and Kunkel G. Antioxidative enzymes in human nasal mucosa after exposure to ozone. Possible role of GSTM1 deficiency. Inflamm Res 52: 51-55, 2003.
181. Pataer A, Nishimura M, Kamoto T, Ichioka K, Sato M, and Hiai H. Genetic resistance to urethan-induced pulmonary adenomas in SMXA recombinant inbred mouse strains. Cancer Res 57: 2904-2908, 1997.
182. Patel AC, Anna CH, Foley JF, Stockton PS, Tyson FL, Barrett JC, and Devereux TR. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines. Carcinogenesis 21: 1691-1700, 2000.
183. Pereira MA, Li Y, Gunning WT, Kramer PM, Al-Yaqoub F, Lubet RA, Steele VE, Szabo E, and Tao L. Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 23: 1185-1192, 2002.
184. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, and Ried T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57: 2331-2335, 1997.
185. Plopper CG, Hyde DM, and Buckpitt AR. Clara cells. In: The Lung: Scientific Foundations, edited by Crystal RG, West JB, Barnes PJ, and Weibel ER. Philadelphia, PA: Lippincott-Raven, 1997, p. 517-533.
186. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in T1r4 gene. Science 282: 2085-2088, 1998.
187. Pope CA III, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, and Heath CW Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 151: 669-674, 1995.
188. Prows DR and Leikauf GD. Quantitative trait analysis of nickel-induced acute lung injury in mice. Am J Respir Cell Mol Biol 24: 740-746, 2001.
189. Prows DR, Shertzer HG, Daly MJ, Sidman CL, and Leikauf GD. Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice. Nat Genet 17: 471-474, 1997.
190. Pryor WA, Squadrito GL, and Friedman M. A new mechanism for the toxicity of ozone. Toxicol Lett 82-83: 287-293, 1995.
191. Quelle DE, Zindy F, Ashmun RA, and Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000, 1995.
192. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, and Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (T1r4). J Exp Med 189: 615-625, 1999.
193. Raizenne M, Neas LM, Damokosh AI, Dockery DW, Spengler JD, Koutrakis P, Ware JH, and Speizer FE. Health effects of acid aerosols on North American children: pulmonary function. Environ Health Perspect 104: 506-514, 1996.
194. Rioux N and Castonguay A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res 58: 5354-5360, 1998.
195. Romieu I, Meneses F, Ramirez M, Ruiz S, Perez Padilla R, Sienra JJ, Gerber M, Grievink L, Dekker R, Walda, I, and Brunekreef B. Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am J Respir Crit Care Med 158: 226-232, 1998.
196. Romieu I, Meneses F, Ruiz S, Sienra JJ, Huerta J, White MC, and Etzel RA. Effects of air pollution on the respiratory health of asthmatic children living in Mexico City. Am J Respir Crit Care Med 154: 300-307, 1996.
197. Roskelley CD and Bissell MJ. The dominance of the microenvironment in breast and ovarian cancer. Semin Cancer Biol 12: 97-104, 2002.
198. Rossing MA. Genetic influences on smoking: candidate genes. Environ Health Perspect 106: 231-238, 1998.
199. Rothwell RI, Kelly SA, and Joslin CA. Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol 4: 9-14, 1985.
200. Ryan J, Barker PE, Nesbitt MN, and Ruddle FH. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J Natl Cancer Inst 79: 1351-1357, 1987.
201. Sargent LM, Senft JR, Lowry DT, Jefferson AM, Tyson FL, Malkinson AM, Coleman AE, and Reynolds SH. Specific chromosomal aberrations in mouse lung adenocarcinoma cell lines detected by spectral karyotyping: a comparison with human lung adenocarcinoma. Cancer Res 62: 1152-1157, 2002.
202. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, and Nakamura Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184-7189, 1990.
203. Schottenfeld D. Etiology and epidemiology of lung cancer. In: Lung Cancer-Principles and Practice (2nd ed.), edited by Pass HI, Mitchell JB, Johnson DH, Turrisi AT, and Minna JD. Philadelphia, PA: Lippincott Williams and Wilkins, 2000, p. 367-388.
204. Schrier DJ, Kunkel RG, and Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 127: 63-66, 1983.
205. Schwartz AG. Genetic susceptibility to lung cancer. In: Lung Cancer-Principles and Practice (2nd ed.), edited by Pass HI, Mitchell JB, Johnson DH, Turrisi AT, and Minna JD. Philadelphia, PA: Lippincott Williams and Wilkins, 2000, p. 389-397.
206. Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J, and Lazo JS. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc Natl Acad Sci USA 96: 4680-4685, 1999.
207. Schwartz J. Air pollution and hospital admissions for the elderly in Detroit, Michigan. Am J Respir Crit Care Med 150: 648-655, 1994.
208. Searle CE and Jones EL. Proceedings: strain differences in the carcinogenic action of N-ethyl-N-nitrosourea (ENU) in mice. Br J Cancer 30: 181, 1974.
209. Sengler C, Lau S, Wahn U, and Nickel R. Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res 3: 7, 2002.
210. Sharplin J and Franko AJ. A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the intermediate and late phases. Radiat Res 119: 15-31, 1989.
211. Shaw GL, Falk RT, Pickle LW, Mason TJ, and Buffler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 44: 429-437, 1991.
212. Shimkin MB and Polissar MJ. Some quantitative observations on the induction and growth of primary pulmonary tumors in strain A mice receiving urethane. J Natl Cancer Inst 16: 75-97, 1955.
213. Sibille Y and Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141: 471-501, 1990.
214. Siegel D, Malkinson AM, and Ross D. Butylated hydroxytoluene (BHT)-mediated increases in NAD(P)H-quinone oxidoreductase (QR) in mouse lung: evidence for the alveolar type II cell as a site of QR activity, Toxicol Appl Pharmacol 96: 68-74, 1988.
215. Silver L. Mouse genetics. Concepts and applications. New York: Oxford University, 1995.
216. Silverman EK, Mosley JD, Palmer LJ, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, Province MA, Rao DC, Reilly JJ, Ginns LC, Speizer FE, and Weiss ST. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet 11: 623-632, 2002.
217. Skillrud DM, Offord KP, and Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 105: 503-507, 1986.
218. Stewart HL, Dunn TB, Snell KC, and Deringer MK. Tumours of the respiratory tract. In: Pathology of Tumours in Laboratory Animals, edited by Turosov VS. Lyon, France: International Agency for Research on Cancer, 1979, p. 251-288.
219. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S, Roczniak S, and Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348-27357, 1995.
220. Suijkerbuijk RF, Sinke RJ, Weghuis DE, Roque L, Forus A, Stellink F, Siepman A, van de Kaa C, Soares J, and Geurts van Kessel A. Amplification of chromosome subregion 12p11.2-p121 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression? Cancer Genet Cytogenet 78: 145-152, 1994.
221. Sunyer J, Anto JM, Murillo C, and Saez M. Effects of urban air pollution on emergency room admissions for chronic obstructive pulmonary disease. Am J Epidemiol 134: 277-286; discussion 287-279, 1991.
222. Takizawa H, Beckmann JD, Shoji S, Claassen LR, Ertl RF, Linder J, and Rennard SI. Pulmonary macrophages can stimulate cell growth of bovine bronchial epithelial cells. Am J Respir Cell Mol Biol 2: 245-255, 1990.
223. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, and Sekiya T. Deletion of three distinct regions on chromosome 13q in human non-small cell lung cancer. Int J Cancer 74: 45-49, 1997.
224. Taylor BA. Recombinant inbred strains. In: Genetic Variants and Strains of the Laboratory Mouse (3rd ed.), edited by Lyon MF, Raston S, and Brown SDM. Oxford: Oxford University, 1996, p. 1597-1659.
225. Thaete LG, Gunning WT, Stoner GD, and Malkinson AM. Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at 28 and 56 weeks after urethan treatment. J Natl Cancer Inst 78: 743-749, 1987.
226. Thaete LG and Malkinson AM. Cells of origin of primary pulmonary neoplasms in mice: morphologic and histochemical studies. Exp Lung Res 17: 219-228, 1991.
227. Thompson JA, Bolton JL, and Malkinson AM. Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice. Exp Lung Res 17: 439-453, 1991.
228. Thompson JA, Carlson TJ, Sun Y, Dwyer-Nield LD, and Malkinson AM. Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion. Toxicology 160: 197-205, 2001.
229. Thompson JA, Malkinson AM, Wand MD, Mastovich SL, Mead EW, Schullek KM, and Laudenschlager WG. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice. Drug Metab Dispos 15: 833-840, 1987.
230. Thompson JA, Schullek KM, Fernandez CA, and Malkinson AM. A metabolite of butylated hydroxytoluene with potent tumor-promoting activity in mouse lung. Carcinogenesis 10: 773-775, 1989.
231. Tockman MS, Anthonisen NR, Wright EC, and Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 106: 512-518, 1987.
232. Trapnell BC and Whitsett JA. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64: 775-802, 2002.
233. Tripodis N, Hart AA, Fijneman RJ, and Demant P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst 93: 1484-1491, 2001.
234. Vane JR, Bunting S, and Moncada S. Prostacyclin in physiology and pathophysiology. Int Rev Exp Pathol 23: 161-207, 1982.
235. Vaucher YE. Bronchopulmonary dysplasia: an enduring challenge. Pediatr Rev 23: 349-358, 2002.
236. Vedal S, Petkau J, White R, and Blair J. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. Am J Respir Crit Care Med 157: 1034-1043, 1998.
237. Venugopal R and Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17: 3145-3156, 1998.
238. Vesterinen E, Pukkala E, Timonen T, and Aromaa A. Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol 22: 976-982, 1993.
239. Vicari AP and Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 13: 143-154, 2002.
240. Wade CM, Kulbokas EJ III, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, and Daly MJ. The mosaic structure of variation in the laboratory mouse genome. Nature 420: 574-578, 2002.
241. Wang D, Lemon WJ, and You M. Linkage disequilibrium mapping of novel lung tumor susceptibility quantitative trait loci in mice. Oncogene 21: 6858-6865, 2002.
242. Wattenberg LW and Estensen RD. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1- butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res 56: 5132-5135, 1996.
243. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, and Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 57: 5489-5492, 1997.
244. Weiss RB. Hypersensitivity reactions. Semin Oncol 19: 458-477, 1992.
245. Witschi H, Espiritu I, and Uyeminami D. Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone. Carcinogenesis 20: 1375-1378, 1999.
246. Wood ME, Kelly K, Mullineaux LG, and Bunn PA Jr. The inherited nature of lung cancer: a pilot study. Lung Cancer 30: 135-144, 2000.
247. Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Henderson BE, and Correa P. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141: 1023-1032, 1995.
248. Xie T, Belinsky M, Xu Y, and Jaiswal AK. ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants. J Biol Chem 270: 6894-6900, 1995.
249. Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, Lindor NM, Myers JL, Wiegert E, Midthun DE, Thibodeau SN, and Krowka MJ. α1-Antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 8: 461-465, 1999.
250. Yao R, Rioux N, Castonguay A, and You M. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res 26: 731-742, 2000.
251. You M, Candrian U, Maronpot RR, Stoner GD, and Anderson MW. Activation of the Ki-ras protooncogene, in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86: 3070-3074, 1989.
252. You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH, and Anderson M. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA 89: 5804-5808, 1992.
253. Zelikoff JT, Sisco MP, Yang Z, Cohen MD, and Schlesinger RB. Immunotoxicity of sulfuric acid aerosol: effects on pulmonary macrophage effector and functional activities critical for maintaining host resistance against infectious diseases. Toxicology 92: 269-286, 1994.
254. Zhang SL, DuBois W, Ramsay ES, Bliskovski V, Morse HC III, Taddesse-Heath L, Vass WC, DePinho RA, and Mock BA. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol Cell Biol 21: 310-318, 2001.
255. Zhang Y, Lefort J, Kearsey V, Lapa e Silva JR, Cookson WO, and Vargaftig BB. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma. Hum Mol Genet 8: 601-605, 1999.